Carmen J. Booth

Yale University — United States

Immunology and Microbiology · Life Sciences

50h-index14.7kcitations153works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Vector-borne infectious diseases(15), MicroRNA in disease regulation(14), Viral Infections and Vectors(13), Virus-based gene therapy research(10), Immunotherapy and Immune Responses(8)

Publications153 total

Unique features of B. burgdorferi peptidoglycan drive persistence in discrete tissues and cause responses that mimic chronic illness 9279
The Journal of Immunology·2025Open Access
CD8 T cells mediate immunosurveillance for neoantigen+ epithelial stem cells in the colon
2025
Bioactive Enhanced Adjuvant Chemokine Oligonucleotide Nanoparticles (BEACONs) for Mucosal Vaccination Against Genital Herpes
2025Open Access
The peptidoglycan of <i>Borrelia burgdorferi</i> can persist in discrete tissues and cause systemic responses consistent with chronic illness
Science Translational Medicine·2025· 11 citedOpen Access
Cas12a-knock-in mice for multiplexed genome editing, disease modelling and immune-cell engineering
Nature Biomedical Engineering·2025· 18 citedOpen Access
65 High-fidelity enhanced AsCas12a knock-in mice for efficient multiplexed gene editing, disease modeling and orthogonal immunogenetics
Regular and Young Investigator Award Abstracts·2024Open Access
High-fidelity enhanced AsCas12a knock-in mice for efficient multiplexed gene editing, disease modeling and orthogonal immunogenetics
2024Open Access
Adiponectin in the mammalian host influences ticks’ acquisition of the Lyme disease pathogen Borrelia
PLoS Biology·2023· 3 citedOpen Access
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis
Science Translational Medicine·2023· 24 citedOpen Access
Supplementary Figure 4 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Data from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figure 4 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figure 2 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Supplementary Materials and Methods and Supplementary Figure Legends from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figure 5 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figure 3 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figure 1 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Data from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figure 5 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figure 2 from miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Richard A. Flavell(9), W. Mark Saltzman(7), Samuel Huber(4), Nicola Gagliani(4), Andrew Wang(4), Till Strowig(3), William O’Connor(3), Ruslan Medzhitov(3), Sukanya Narasimhan(3), Erol Fikrig(3), Eran Elinav(2), Stephanie C. Eisenbarth(2), Masahito Kamanaka(2), Francis J. Huber(2), Lidia Bosurgi(2), Bo Hu(2), Andrew Murphy(2), David M. Valenzuela(2), George D. Yancopoulos(2), Sarah C. Huen(2)